486 related articles for article (PubMed ID: 26297827)
1. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
3. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
4. Spin-labeled derivatives of cardiotonic steroids as tools for characterization of the extracellular entrance to the binding site on Na
Guo JH; Jiang RW; Andersen JL; Esmann M; Fedosova NU
FEBS J; 2018 Jun; 285(12):2292-2305. PubMed ID: 29688626
[TBL] [Abstract][Full Text] [Related]
5. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
6. Comparative Action of Cardiotonic Steroids on Intracellular Processes in Rat Cortical Neurons.
Lopachev AV; Lopacheva OM; Nikiforova KA; Filimonov IS; Fedorova TN; Akkuratov EE
Biochemistry (Mosc); 2018 Feb; 83(2):140-151. PubMed ID: 29618300
[TBL] [Abstract][Full Text] [Related]
7. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
[TBL] [Abstract][Full Text] [Related]
8. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
Fedorova OV; Bagrov AY
Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
[TBL] [Abstract][Full Text] [Related]
10. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
[TBL] [Abstract][Full Text] [Related]
11. Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex.
Laursen M; Gregersen JL; Yatime L; Nissen P; Fedosova NU
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1755-60. PubMed ID: 25624492
[TBL] [Abstract][Full Text] [Related]
12. Conformational states of the pig kidney Na
Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
[TBL] [Abstract][Full Text] [Related]
13. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
14. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
[TBL] [Abstract][Full Text] [Related]
15. The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking.
Liu J; Xie ZJ
Biochim Biophys Acta; 2010 Dec; 1802(12):1237-45. PubMed ID: 20144708
[TBL] [Abstract][Full Text] [Related]
16. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
18. Palytoxin-induced channel formation within the Na+/K+-ATPase does not require a catalytically active enzyme.
Scheiner-Bobis G; Schneider H
Eur J Biochem; 1997 Sep; 248(3):717-23. PubMed ID: 9342222
[TBL] [Abstract][Full Text] [Related]
19. New insights into the regulation of Na+,K+-ATPase by ouabain.
Silva E; Soares-da-Silva P
Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
[TBL] [Abstract][Full Text] [Related]
20. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
Tao QF; Soszynski PA; Hollenberg NK; Graves SW
J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
